Total Return chart Alkermes plc

Stocks

Market Closed - Nasdaq 20:00:00 30/10/2026 GMT			5-day change	1st Jan Change
45.34 ^USD	-0.07%		+3.92%	+62.04%

10-30	Alkermes Initiates Phase 2 Study of Alks 7290 as Adjunctive Treatment for Major Depressive Disorder	CI
10-30	Alkermes Launches Phase 2 Study of ALKS 7290 as Adjunctive Therapy to Antidepressants in Major Depressive Disorder Patients	MT

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.